CBT-161
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
CBT-161
Description:
CBT-161 is an ADC that STI-A0602, the monoclonal antibody targeting c-Met, links tubulin inhibitors or DNA damaging agents via C-lock. Preclinical study showed that CBT-161 significantly inhibited tumor growth.
COA:
Inquire
MSDS:
Inquire
Targets:
c-Met
Current Developer:
Sorrento Therapeutics